CCCC
Price
$2.33
Change
+$0.02 (+0.87%)
Updated
Jan 14 closing price
Capitalization
225.81M
35 days until earnings call
Intraday BUY SELL Signals
GLUE
Price
$24.06
Change
+$0.07 (+0.29%)
Updated
Jan 14 closing price
Capitalization
1.83B
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs GLUE

Header iconCCCC vs GLUE Comparison
Open Charts CCCC vs GLUEBanner chart's image
C4 Therapeutics
Price$2.33
Change+$0.02 (+0.87%)
Volume$1.03M
Capitalization225.81M
Monte Rosa Therapeutics
Price$24.06
Change+$0.07 (+0.29%)
Volume$1.26M
Capitalization1.83B
CCCC vs GLUE Comparison Chart in %
CCCC
Daily Signal:
Gain/Loss:
GLUE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CCCC vs. GLUE commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and GLUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CCCC: $2.33 vs. GLUE: $24.06)
Brand notoriety: CCCC and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 63% vs. GLUE: 71%
Market capitalization -- CCCC: $225.81M vs. GLUE: $1.83B
CCCC [@Biotechnology] is valued at $225.81M. GLUE’s [@Biotechnology] market capitalization is $1.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileGLUE’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • GLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while GLUE’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 6 bearish.
  • GLUE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +4.95% price change this week, while GLUE (@Biotechnology) price change was +3.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 19, 2026.

GLUE is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.83B) has a higher market cap than CCCC($226M). GLUE YTD gains are higher at: 53.444 vs. CCCC (21.990). GLUE has higher annual earnings (EBITDA): 16.8M vs. CCCC (-105.05M). GLUE has more cash in the bank: 391M vs. CCCC (192M). GLUE has less debt than CCCC: GLUE (40.2M) vs CCCC (61.5M). GLUE has higher revenues than CCCC: GLUE (182M) vs CCCC (30.1M).
CCCCGLUECCCC / GLUE
Capitalization226M1.83B12%
EBITDA-105.05M16.8M-625%
Gain YTD21.99053.44441%
P/E RatioN/A75.16-
Revenue30.1M182M17%
Total Cash192M391M49%
Total Debt61.5M40.2M153%
TECHNICAL ANALYSIS
Technical Analysis
CCCCGLUE
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 8 days ago
89%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
GLUE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLHK32.25N/A
N/A
BlueHarbor Bank (Mooresville NC)
EREPF0.10N/A
N/A
Zonte Metals, Inc.
DKILY12.35-0.02
-0.16%
Daikin Industries Ltd.
TMVWY3.45-0.06
-1.71%
TeamViewer SE
DNTUY19.82-2.44
-10.94%
Dentsu Group Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with GLUE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+0.87%
GLUE - CCCC
40%
Loosely correlated
+0.29%
BEAM - CCCC
40%
Loosely correlated
+2.49%
AXON - CCCC
40%
Loosely correlated
-1.92%
XNCR - CCCC
40%
Loosely correlated
+3.66%
VYGR - CCCC
38%
Loosely correlated
+2.74%
More

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RVMD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
+0.29%
RVMD - GLUE
46%
Loosely correlated
+1.06%
KURA - GLUE
44%
Loosely correlated
+1.63%
CRNX - GLUE
41%
Loosely correlated
+2.04%
IMNM - GLUE
41%
Loosely correlated
+3.08%
ERAS - GLUE
41%
Loosely correlated
+10.73%
More